Notice of the Meeting | About the 7th Advanced Training Course for Special Principals of Non clinical Safety Evaluation of Drugs
2024/08/12
Shandong Xinbo Drug Research Co., Ltd. was honored to jointly organize this training with China Ocean University!
Various drug security centers and related research institutions: With the continuous introduction of my country's new drug research and development encouragement and innovation policies, the speed of new drug review has accelerated, the development of drug safety evaluation is facing huge opportunities and challenges; In the new situation, the ability and requirements for safety evaluation of professional talents are getting higher and higher.
Therefore, in order to further promote the improvement of the talent team (SD) talent team level in the field of drug safety evaluation, promote the improvement of the overall capabilities of the drug safety evaluation industry in my country, and meet the needs of my country's rapidly developing the needs of the pharmaceutical industry. The Professional Committee of the Chinese Pharmaceutical Society's Drug Safety Evaluation Research is planned to hold the "Seventh Drug Safety Evaluation Senior Training Course" in Qingdao City, Shandong Province from August 24th to 25th, 2024.
The theme of this training course is "Non -clinical Safety Evaluation of Drugs in New Products, New Technology, and New Situation. The training content is divided into two parts: (1) general, regulations and guidelines; (2) non -clinical drugs Research. The main training and discussion contents include: the focus of computer systems, the focus of the dual newspaper test, the stem cell therapy products, the new type of agent and the vaccine, the safety evaluation of the MRNA drugs, the evaluation strategy and case analysis, the macromolecular immunogenic nature Method verification and evaluation strategies and points.
This training course adopts lectures and interactive exchanges, inviting authoritative experts in the field of non -clinical safety evaluation in domestic drugs and senior domestic SDs to combine the special cases that they have completed. Analysis. Each report reserves full discussion and time to answer the time, improves the effective interaction between the lecturers and the students, and solves the problems that everyone encountered in practice in practice, so as to achieve the goal of comprehensively improve the level of SD technology.
In addition to discussing and exchanges on the content of the lectures, this training course reserves a question of questioning and questioning. Welcome to sort out and collect problems, confusion and thinking encountered in the usual SD work in advance, and include good practices and suggestions. In the mailbox of the conference group, we collected and sorted out, and answered, discussed, and exchanged at the meeting. On the last day of the training, students will be organized to evaluate, and the test certificate will be issued qualified.
This training course is hosted by the Professional Committee of the China Pharmaceutical Society of Pharmaceutical Safety Evaluation and hosted by Shandong Xinbo Pharmaceutical Research Co., Ltd. and Ocean University of China. The specific information is as follows:
1. Training arrangements:
1. Report time: August 23, 2024
2. Training time: August 24 to 25, 2024
3. Training location: Huanghai Hotel, Qingdao, Shandong (No. 75, Yan'an One Road, Qingdao City Tel 0532-55769999)
2. Training costs:
1500 yuan/person. The costs include training fees, data fees, etc. After paying the fee, please send the remittance voucher and send the information to the contact message to the contact in order to check the inquiries. Send an email confirmation within 1 week after receiving the training fee. If you do not receive a confirmation email, please call.
The issue of invoices: 1) The invoice is an electronic invoice; 2) the on -site can only be paid in cash, and the contact name, mailbox and mobile phone number information can be reserved. After the training, send electronic invoices within 10 working days to reserved mailboxes.
Bank remittance information
Account opening: Chinese Pharmaceutical Association
Account Bank: Bank of China Headquarters Business Department
Account 778350009320 remittance
Please indicate: "SD training class registration fee in 2024"
Accommodation fee: 680 yuan room/day (the standard room contains breakfast). Arrange accommodation uniformly, and the cost is at its own expense. By then, the local peak season is tense.
3. Training registration and cooperation consultation: Please return to the form of emails before June 1, 2024, in order to reserve rooms and arrange conference work. Training registration contact person:
Xia Ying (Professional Committee of the Chinese Pharmaceutical Society of Pharmaceutical Safety Evaluation); Email: ncsed-huiyi0163.com (Xia Ying);
Mobile: 18810481860 (Xia Ying)
18953440388 (Zhang Li)
13810100161 (Zhang Xi)
Attachment: Senior training course for the seventh drug non -clinical safety evaluation of the topic of the topic of the person in charge of the person in charge
Shandong Xinbo Pharmaceutical Research Co., Ltd. was established in April 2010. It is a national high-tech enterprise, Shandong Enterprise Technology Center, Shandong Gazelle Enterprise, and a research service-oriented enterprise that integrates pharmacological research, toxicology research, drug analysis and testing services, animal pathology testing, and medical device evaluation services.
We have completed preclinical safety evaluations for over 300 innovative drugs, including chemical drugs, traditional Chinese medicine and natural medicines, biological products, preventive and therapeutic vaccines, monoclonal antibodies, cell therapy products, medical devices, and other varieties.
Phone: 0534-5056588 0531-68801033 Postal Code: 251500 Website: www.xinbo.cn Email: bd@xinbo.cn
Address: 1308 Fumin Road, Linyi Economic Development Zone, Dezhou City, Shandong Province
5th Floor, Building A, Lishan International Cell Medicine Industrial Park, Jinan City, Shandong Province